SLDB Solid Biosciences Inc.companySEC Filings & Insider Trading Activity 2026
Latest Solid Biosciences Inc. (SLDB) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on March 19, 2026, a 10-Q quarterly report filed on November 3, 2025, an 8-K current report filed on April 10, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Solid Biosciences Inc. (SLDB) (SEC CIK 1707502), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 7.01: Regulation FD Disclosure
- • Updated corporate presentation published March 11, 2026 on Solid Biosciences' website
- • Reg FD disclosure ensures institutional and retail investors receive simultaneous access to the same strategic update
Item 8.01: Other Events
- • SGT-003 dosed 40 participants at 1E14vg/kg; Day 360 biopsy data (n=3) shows microdystrophin expression rising to 91% by western blot vs 60% at Day 90
- • Key biomarker reductions at Day 90: CK -38%, ALT -43%, LDH -46%, plus 44% reduction in eMHC-positive fibers suggesting disruption of Duchenne's degeneration-regeneration cycle
Item 1.01: Entry into a Material Definitive Agreement
- • Private placement to institutional accredited investors and QIBs under Section 4(a)(2) exemption — no SEC registration required at issuance
- • Securities include both common Shares and Pre-Funded Warrants, typical structure when investors want to avoid ownership thresholds
Item 2.02: Results of Operations and Financial Condition
- • Q1 2025 earnings release referenced via exhibit — no financial figures disclosed in filing body
- • Full results available in attached press release exhibit (Reg FD safe harbor language only in this section)
Item 8.01: Other Events
- • Cash runway extended into H1 2028 via Private Placement proceeds combined with existing cash/securities
- • Explicit warning: current funds insufficient to complete development of any pipeline candidate — additional raises inevitable
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Solid Biosciences Inc. (SLDB) 8-K current reports disclosing material events.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Apr 10, 2026 | — | — | — |
10-K | Mar 19, 2026 | Dec 31, 2025 | — | |
8-K | Mar 12, 2026 | — | Analysis | — |
8-K | Mar 6, 2026 | — | Analysis | — |
10-Q | Nov 3, 2025 | Sep 30, 2025 | — | |
10-Q | Aug 12, 2025 | Jun 30, 2025 | — | |
10-Q | May 15, 2025 | Mar 31, 2025 | — | |
10-K | Mar 6, 2025 | Dec 31, 2024 | — | |
10-Q | Nov 6, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 13, 2024 | Jun 30, 2024 | — | |
10-Q | May 15, 2024 | Mar 31, 2024 | — | |
10-K | Mar 13, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 8, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 14, 2023 | Jun 30, 2023 | — | |
10-Q | May 11, 2023 | Mar 31, 2023 | — | |
10-K | Mar 23, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 10, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 11, 2022 | Jun 30, 2022 | — | |
10-Q | Apr 27, 2022 | Mar 31, 2022 | — | |
10-K | Mar 14, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 3, 2021 | Sep 30, 2021 | — | |
10-Q | Aug 16, 2021 | Jun 30, 2021 | — | |
10-Q | May 14, 2021 | Mar 31, 2021 | — | |
10-K | Mar 15, 2021 | Dec 31, 2020 | — | |
10-Q | Nov 5, 2020 | Sep 30, 2020 | — |
Frequently Asked Questions
What are the latest SLDB SEC filings in 2026?
Solid Biosciences Inc. (SLDB) has filed a 10-K annual report on March 19, 2026, a 10-Q quarterly report on November 3, 2025, an 8-K current report on April 10, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did SLDB file its most recent 10-K annual report?
Solid Biosciences Inc. (SLDB) filed its most recent 10-K annual report on March 19, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view SLDB 10-Q quarterly reports?
Solid Biosciences Inc. (SLDB)'s most recent 10-Q quarterly report was filed on November 3, 2025. SignalX displays every SLDB 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has SLDB filed recently?
Solid Biosciences Inc. (SLDB)'s most recent 8-K was filed on April 10, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find SLDB insider trading activity (Form 4)?
SignalX aggregates every SLDB Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does SLDB file with the SEC?
Solid Biosciences Inc. (SLDB) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new SLDB filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Solid Biosciences Inc. (SLDB).
What is SLDB's SEC CIK number?
Solid Biosciences Inc. (SLDB)'s SEC CIK (Central Index Key) number is 1707502. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1707502 to look up all SLDB filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find SLDB return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from Solid Biosciences Inc. (SLDB) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of Solid Biosciences Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 36+ filings.